Eplerenone Versus PDT: Comparative Study by OCTA

Status Completed

Clinical Trial Summary

The study aims to analyze the changes in OCTA parameters and in choroidal thickness in patients affected by central serous chorioretinopathy treated by oral eplerenone and half-fluence photodynamic therapy.

Clinical Trial Description

Central serous chorioretinopathy (CSC) is a chorioretinal disease characterized by serous detachment due to the dilatation and hyperpermeability of choroidal vessels resulting in the accumulation of serous fluid between the neurosensory retina and the retinal pigment epithelium. Several studies reported the efficacy of half-fluence photodynamic therapy (PDT) and oral eplerenone in the CSC treatment inducing a reduction of the choroidal hyperpermeability and remodeling the choroidal vascularization. This retrospective study aims to perform a quantitative analysis of retinal and CC vessel density by OCTA at baseline, 3 and 6 months in patients underwent PDT and patients underwent eplerenone. ;

Study Design

Related Conditions & MeSH terms

Central Serous Chorioretinopathy

Clinical Trial Details

NCT number	NCT05104138
Study type	Observational
Source	Federico II University
Contact
Status	Completed
Phase
Start date	October 1, 2015
Completion date	November 30, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03497000` - Effects of OCTA-guided PDT in Acute CSC	N/A
Recruiting	`NCT03692169` - The Changes of Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes With CSC
Not yet recruiting	`NCT02215330` - A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy	Phase 2/Phase 3
Completed	`NCT01971190` - Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy	Phase 2
Completed	`NCT01990677` - Eplerenone for the Treatment of Central Serous Chorioretinopathy	N/A
Active, not recruiting	`NCT01710332` - The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy	Phase 2
Active, not recruiting	`NCT00403884` - Selective RPE Laser Treatment (SRT) for Various Macular Diseases	N/A
Recruiting	`NCT05570591` - Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy	N/A
Recruiting	`NCT05589974` - Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
Completed	`NCT01880788` - Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD	N/A
Terminated	`NCT01982383` - Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy	N/A
Completed	`NCT01327170` - Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy	N/A
Completed	`NCT01019668` - Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy	N/A
Recruiting	`NCT06346405` - Central Serous Chorioretinopathy and Micropulse Laser Treatment
Recruiting	`NCT02141308` - OCT in Rare Chorioretinal Diseases
Completed	`NCT01822561` - Eplerenone for Central Serous Chorioretinopathy	Phase 2
Completed	`NCT00802906` - Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)	N/A
Withdrawn	`NCT05679180` - Navigated Microsecond Laser for Chronic Central Serous Chorioretinopathy: MICROPULSE	N/A
Completed	`NCT05686421` - Comfortable and Stabilizing Chin & Forehead Rest Attachment for Slit Lamp Configurations	N/A
Completed	`NCT03758963` - Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy	N/A